SnapBill MD
All codes

G359 – Special single agent or multi-agent therapy

OHIP Diagnostic and Therapeutic Procedures Code — DIAGNOSTIC AND THERAPEUTIC PROCEDURES · Schedule of Benefits

Special single agent or multi-agent therapy – chemotherapy and/or biologic agent(s) with major toxicity that require frequent monitoring and prolonged administration periods and may require immediate intervention by the physician. General Chemotherapy Requirements: This service is for the pharmacologic therapy of malignancy or autoimmune disease, with administration supervised by a physician for intravenous infusion. The physician must be available to intervene in a timely fashion at the initiation and for the duration of the prescribed therapy to manage immediate and delayed toxicities. The fee for chemotherapy and patient assessment provided by a physician includes all patient assessments by any physician for a 24 hour period following treatment administration. [Commentary from Schedule] Examples of special agent therapy include: • high-dose methotrexate with folinic acid rescue • methotrexate given in a dose of greater than 1 g/m2 • high dose cisplatin greater than 75 mg/m2 given concurrently with hydration and osmotic diuresis • high dose cystosine, arabinoside (greater than 2 g/m2) • high dose cyclophosphamide (greater than 1 g/m2) • ifosfamide with MESNA protection • combination of biologic agents with complex chemotherapy.

G381, G345 and G359 are only eligible for payment with respect to the following classes of biologic agents: a. monoclonal antibodies; and b. cytokines.

G381, G345, G359, G075 and G390 include venipuncture, establishment of any vascular access line and administration of agent(s).

Ready to bill this code?

SnapBill makes OHIP billing simple — auto-filled codes, validation, and batch submission.

We use cookies to measure site usage and improve your experience. You can manage your preferences at any time.